Bradley Merrill Thompson, Member of the Firm, presents “FDA’s Regulation of mHealth and Decision Support Software: Past, Present and Future” at the iMedicine & Mobile Life Sciences World Summit, which runs from May 16 to 17.
This session will describe where FDA has been in its regulatory approach to mHealth related technologies, the current issues of debate and some guesswork on where FDA might go from here. 2012 promises to be an active year for FDA, with an anticipated final draft of its mobile medical app guidance and a first proposed draft of its new approach to clinical decision support software. This includes such relatively simple software as drug dosage calculators.
For more information, visit iMedicineSummit.com.